Goldman Sachs (NYSE:GS) may acquire 26% stake in Opto Circuits as reported by the Economic Times of India. Headquartered in Bangalore Opto Circuits specialises in vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies.
Neither GS or Opto circuits commented on the news. The Opto board will meet early next month to approve Q3 results at which time they are expected to clear the deal.
Goldman has invested some $8 Billion in Healthcare companies over 30 countries.
Opto Circuits has acquired over the past seven to eight years US-based Criticare Systems, Polco Labs, Unetixs Vascular and Cardiac Sciences Corp and a German company EuroCOR. In India, it took over kolkata-based NS Remedies.
The 26% will include purchases of existing shares and fresh capital. GS will appoint two members to the board.
George Gutowski writes from a caveat emptor perspective.